We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

995:HKEXAnhui Expressway Company Limited Class H Analysis

Data as of 2026-06-13 - not real-time

MYR 0.21

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

RGT Berhad is trading at MYR 0.205, just above its 20‑day (MYR 0.199) and 50‑day (MYR 0.187) simple moving averages but still below the 200‑day SMA (MYR 0.225), indicating a short‑term price lift while the longer‑term trend remains neutral. The RSI sits at 56, suggesting neither overbought nor oversold conditions, yet the MACD line (0.0045) is marginally under the signal line (0.0047), producing a bearish signal and a negative histogram. Volume is on a decreasing trajectory, and the price is sandwiched between a near‑term support of MYR 0.18 and resistance at MYR 0.21, leaving limited upside in the immediate term.
Fundamentally, the company posted a 36.8% revenue contraction, negative operating (‑13.3%) and profit margins (‑4.2%), and a trailing EPS of ‑0.01, underscoring earnings weakness. Debt levels are high at MYR 67.8 million versus cash of MYR 12.2 million, yielding a debt‑to‑equity ratio of 46.6, while the price‑to‑book of 0.5 signals a discount to net assets. The DCF‑derived fair value (MYR 0.108) is roughly half the current market price, suggesting the shares are overvalued on cash‑flow grounds, and the stock carries a high 30‑day volatility of 57%.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Bearish MACD crossover
  • Price approaching resistance with decreasing volume
  • High short‑term volatility

Medium Term

1–3 years
Cautious
Model confidence: 7/10

Key Factors

  • Continued revenue decline and negative margins
  • Elevated debt‑to‑equity ratio
  • Current price above DCF fair value

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Discounted price‑to‑book ratio
  • Diversified geographic footprint
  • Potential for restructuring or asset‑based recovery

Key Metrics & Analysis

Financial Health

Revenue Growth-36.80%
Profit Margin-4.17%
ROE-4.18%
ROA-0.99%
Debt/Equity46.61
P/B Ratio0.5
Op. Cash FlowMYR12.7M
Free Cash FlowMYR7.0M

Technical Analysis

TrendNeutral
RSI56.2
SupportMYR 0.18
ResistanceMYR 0.21
MA 20MYR 0.20
MA 50MYR 0.19
MA 200MYR 0.22
MACDBearish
VolumeDecreasing
Fear & Greed Index89.86

Valuation

Fair ValueMYR 0.11
GradeFair
TypeValue

Risk Assessment

Beta0.51
Volatility57.15%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.